Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

This a repost of mine from yahoo site

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
vorlon1966 Member Profile
Member Level 
Followed By 28
Posts 469
Boards Moderated 0
Alias Born 12/05/13
160x600 placeholder
Provectus Biopharmaceuticals’ PV-10 Clinical Data on the Treatment of Melanoma to Be Presented at European Society for Medi... "Business Wire" - 7/23/2014 9:13:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/23/2014 6:06:15 AM
Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Aga... "Business Wire" - 7/15/2014 8:32:00 AM
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Provectu... "Business Wire" - 7/8/2014 4:14:00 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 7/8/2014 2:39:27 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/8/2014 6:06:30 AM
Provectus Updates Shareholders in Its Annual CEO Letter "Business Wire" - 7/8/2014 6:00:00 AM
Shareholder Rights Law Firm Johnson & Weaver, LLP Reminds Investors of Provectus Biopharmaceuticals, Inc. ... "Business Wire" - 7/3/2014 10:34:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2014 10:23:05 AM
Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and ... "PR Newswire (US)" - 6/27/2014 1:58:00 PM
Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc. Announced by Glancy Binkow & Goldberg LLP "Business Wire" - 6/26/2014 10:32:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/19/2014 6:02:46 AM
Provectus Biopharmaceuticals, Inc. to Hold Conference Call Today to Detail Outline of Phase 3 Clinical Trial of PV-10 in Mela... "Business Wire" - 6/19/2014 6:00:00 AM
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Provectus Biopharmaceuticals, Inc. "Business Wire" - 6/18/2014 5:42:00 PM
Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith "Business Wire" - 6/17/2014 10:32:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/17/2014 6:06:29 AM
Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Provectus Biopharm... "PR Newswire (US)" - 6/16/2014 4:18:00 PM
Lifshitz & Miller Law Firm Announces Investigation of Annie's, Inc., Montage Technology Group Limited, OpenTable, Inc., Prove... "PR Newswire (US)" - 6/14/2014 10:01:00 AM
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Provectus Biopharmaceuticals... "PR Newswire (US)" - 6/14/2014 9:32:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/12/2014 6:04:25 AM
Provectus Biopharmaceuticals to Discuss Outline of Phase 3 Clinical Trial Of PV-10 To Treat Melanoma on Conference Call "Business Wire" - 6/12/2014 6:00:00 AM
Brower Piven Encourages Investors With Losses Over $100,000 In Provectus Biopharmaceuticals, Inc. To Conta... "Business Wire" - 6/6/2014 3:10:00 PM
Investigation on Behalf of Provectus Biopharmaceuticals, Inc. Investors Announced by Law Offices of Howard... "Business Wire" - 6/3/2014 5:32:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/3/2014 8:22:22 AM
PV-10 Data Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting Defines Path Forward for Provectus Bi... "Business Wire" - 6/3/2014 8:22:00 AM
vorlon1966 Member Level  Saturday, 12/28/13 12:08:00 PM
Re: buccaneer1961 post# 919
Post # of 6204 
This a repost of mine from yahoo site answering questions and comments.

They never failed
They shut down photogen to start pvct when they figured out they had a better product
They did get paid a few years a bunch.... They also are getting a product to market for around $130mm instead of $1.5 billion and in less time than normal.... We benefited from that because there are no partners to share in the end game... Probably would not be an end game otherwise....they would have taken over and you might have gotten a few bucks increase instead of the big payoff that's coming
They did not go for pIII right away when they realized they could invent a new synthesis for rb that can be approved internationally for oncology....99% purity
Patent awarded this year ....you have to go into pIII with the drug that gets approved...so they waited for the patent
PIII? No mention in 8k..... What was mentioned was btd and aa
Deliberate omission? Judge for yourself.
Large production runs done for Nda and ready to ship...hmmmmm.
Second Pfizer guy on advisory board with Chinese pharma experience
They have been working on a Chinese regional deal waiting on FDA clarity....hmmmmm
First Pfizer board member is an acquisition specialist.....hmmmmm
They changed their name and state of incorporation......around same time as FDA meeting.....hmmmmm
Pfizer losing patents on Lipitor and Viagra .....hmmmmm

You guys not getting this......???? hmmmmmm...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist